Search results for "Highlights"


 
Results 31 - 40 of about 42 for "Highlights".

8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C

The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
March 2017

Guideline released on treatment of Helicobacter pylori infection

Clarithromycin triple therapy should be used for first-line treatment of Helicobacter pylori infection only in patients with no history of macrolide exposure who live in areas where H. pylori resistance to clarithromycin is known to be low, among
January 2017

Tofacitinib more effective than placebo for ulcerative colitis, industry-funded study finds

The drug was evaluated in three multicenter, phase 3, randomized, double-blind, placebo-controlled trials involving patients with moderately to severely active disease.
May 2017

Endoscopic eradication therapy plus reflux control associated with decreased Barrett's recurrence rates

Standard reflux management protocol involved initial consultation that emphasized reflux control and proton-pump inhibitor (PPI) adherence, initiation or continuation of PPI therapy as described, medication reconciliation and assessment or
February 2017

Spotlight on esophageal adenocarcinoma

Although this study highlights a potential role of HPV status in the prognosis of esophageal adenocarcinoma, “ the use of HPV as a predictive marker for treatment remains unproven,” an accompanying commentary
August 2018

Highlights

Two recent studies looked at changes in colorectal cancer (CRC) incidence over time, one in U.S. adults ages 40 to 49 years and one in European adults ages 20 to 49 years.
May 2019

Insufficient evidence to support gluten-free diet for IBS, meta-analysis finds

Included trials evaluated an exclusion diet versus an alternative or usual diet and assessed improvement in either global symptoms of irritable bowel syndrome (IBS) or abdominal pain.
August 2018

GI bleeding less common in U.S. veterans on NOACs than those on warfarin

Significant bleeding occurred in 2.5% of the patients on warfarin and 0.6% of the patients on non-vitamin K antagonist oral anticoagulants (NOACs).
March 2017

Pioglitazone associated with improved advanced fibrosis in patients with NASH

A recent meta-analysis looked at randomized clinical trials that examined the effect of thiazolidinediones on liver histology in patients with nonalcoholic steatohepatitis (NASH).
March 2017

Spotlight on nonalcoholic fatty liver disease and cardiac risk

Additionally, our results highlight the potential clinical utility of echocardiography for assessing NAFLD-related HF risk.
August 2017

Result Page: Prev   1   2   3   4   5   Next